HCV NS3 PROTEASE INHIBITORS

Disclosed are compounds comprising a cyclopropyl group and a pyrido group represented by general formula (I), or pharmaceutically acceptable salts or hydrates thereof. Also disclosed is the use of the compounds for treating an infection by hepatitis C (HCV) in subject.

Saved in:
Bibliographic Details
Main Authors POMPEI, MARCO, FERRARA, MARCO, HARPER, STEVEN, LIVERTON, NIGEL, J, PETROCCHI, ALESSIA, ROMANO, JOSEPH, J, RUDD, MICHAEL, T, SUMMA, VINCENZO, GILBERT, KEVIN, F, MCCAULEY, JOHN, A, DI FRANCESCO, MARIA, EMILIA, MCINTYRE, CHARLES, J
Format Patent
LanguageEnglish
Published 25.11.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds comprising a cyclopropyl group and a pyrido group represented by general formula (I), or pharmaceutically acceptable salts or hydrates thereof. Also disclosed is the use of the compounds for treating an infection by hepatitis C (HCV) in subject.
Bibliography:Application Number: NZ20070576345